These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2043173)

  • 1. Antiarrhythmic properties of benzyl-triamterene derivatives in the coronary artery ligated and reperfused rat.
    Busch AE; Netzer T; Ullrich F; Mutschler E
    Arzneimittelforschung; 1991 Feb; 41(2):125-7. PubMed ID: 2043173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic properties of triamterene derivatives in the coronary artery ligated rat model.
    Busch AE; Ullrich F; Mutschler E
    Arch Pharm (Weinheim); 1991 Nov; 324(11):895-8. PubMed ID: 1804067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro testing of triamterene derivatives for antiarrhythmic activity.
    Busch AE; Ullrich F; Mutschler E
    Arch Pharm (Weinheim); 1991 Jan; 324(1):39-44. PubMed ID: 2043041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade.
    Abraham S; Beatch GN; MacLeod BA; Walker MJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1166-73. PubMed ID: 2557414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of antiarrhythmic drugs to affect epicardial delay during acute experimental coronary artery occlusion and reperfusion: correlation with lack of antiarrhythmic efficacy.
    Naito M; Michelson EL; Kmetzo JJ; Kaplinsky E; Dreifus LS
    J Pharmacol Exp Ther; 1981 Aug; 218(2):475-80. PubMed ID: 7252847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by antiarrhythmic drugs against ischemia-induced arrhythmias occurring during coronary artery occlusion in the rat.
    Gerbsch S; Hagen A
    Biomed Biochim Acta; 1987; 46(8-9):S572-5. PubMed ID: 3435514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
    Manning AS; Bruyninckx C; Ramboux J; Chatelain P
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):453-61. PubMed ID: 8583788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W; Wainwright CL
    Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemia/reperfusion injury in rats.
    Huang SS; Liu SM; Lin SM; Liao PH; Lin RH; Chen YC; Chih CL; Tsai SK
    Clin Biochem; 2005 Oct; 38(10):943-7. PubMed ID: 16098504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
    Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
    Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lidocaine on catecholamine release in the ischemic rat heart.
    Polwin W; McDonald FM; Brinkmann C; Hirche H; Addicks K
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):6-11. PubMed ID: 2434796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of newer antiarrhythmic drugs in the management of patients with ventricular arrhythmias.
    Cain ME
    Angiology; 1988 Jul; 39(7 Pt 2):668-83. PubMed ID: 3044200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of straight-chain and branched-chain acidic triamterene derivatives.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1986 Feb; 36(2):213-5. PubMed ID: 3964327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute management of ventricular arrhythmias: role of antiarrhythmic agents.
    Singh BN
    Pharmacotherapy; 1997; 17(2 Pt 2):56S-64S; discussion 89S-91S. PubMed ID: 9085341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.